Determinants of Response to Immune Checkpoint Blockade in Pleural Mesothelioma: Molecular, Immunological, and Clinical Perspectives

Martina Delsignore, Gaia Cassinari, Simona Revello, Luigi Cerbone, Federica Grosso, Marcello Arsura, Chiara Porta, Alfonso Baldi · 2025

Read Determinants of Response to Immune Checkpoint Blockade in Pleural Mesothelioma: Molecular, Immunological, and Clinical Perspectives by Martina Delsignore, Gaia Cassinari, Simona Revello, Luigi Cerbone, Federica Grosso, Marcello Arsura, Chiara Porta, Alfonso Baldi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12731717.txt.

Description

Martina Delsignore and co-authors review what decides whether immune therapy works against pleural mesothelioma, in a 2025 paper. The cancer is rare and long had few options. A dual checkpoint drug pairing helped, but responses vary wildly and survival gains stay modest. Tumor subtype matters: the two growth patterns carry different gene faults and immune neighborhoods.

The review weighs tumor-side factors like mutation load and checkpoint levels, and host-side ones like immune cell mix, tissue scaffolding, and gut microbes. It then surveys add-on strategies in trials: chemotherapy, radiation, surgery, gene-silencing drugs, vessel blockers, vaccines, and virus therapies. The authors argue matching patients by layered profiles is the way forward.

Catalog record

CREATORMartina Delsignore, Gaia Cassinari, Simona Revello, Luigi Cerbone, Federica Grosso, Marcello Arsura, Chiara Porta, Alfonso Baldi
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE95 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12731717

Browse the full library · About the Tower of Babel